Biotech

All Articles

Sanofi pays $110M upfront for late-stage radioligand treatment

.Sanofi has actually made an overdue entry to the radioligand celebration, spending one hundred thou...

F 2G increases $100M for second try to obtain new antifungal to market

.After F2G's initial attempt to get a brand-new training class of antifungal to market was derailed ...

Moderna targets $1.1 B in R&ampD investing slices, drops 5 courses amid productivity tensions

.Moderna has promised to cut R&ampD costs through $1.1 billion through 2027. The selection to retrac...

Sanofi's $80M bank on Key dystrophy medication ends in stage 3 crash

.Just four months after Sanofi wager $80 thousand in upfront cash money on Key Therapeutics' losmapi...

Oncternal share sinks 60% amid cutbacks, trial discontinuations

.Cancer cells provider Oncternal Therapeutics is actually folding all its own professional tests and...

Roche is holding out hopes that its own injectable being overweight prospect might eventually display 25% weight reduction in late-stage trial

.Roche is actually holding out chances that its injectable excessive weight prospect can inevitably ...

Novo Nordisk hails 'amazing' effective weight loss lead for dual-acting dental drug in very early test

.Novo Nordisk has actually lifted the cover on a period 1 test of its dental amylin and also GLP-1 r...

AbbVie files suit BeiGene over blood stream cancer cells medicine trade secrets

.Just a few brief full weeks after gaining an FDA Fast lane tag for its investigational BTK degrader...

Lilly supplies one-two blow with 2nd tranche of beneficial records on weekly insulin candidate

.Shortly after a beneficial information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based...

BridgeBio reduces genetics treatment budget as medical records dissatisfy

.BridgeBio Pharma is actually slashing its own genetics therapy budget and pulling back from the mod...